Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-KB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines
- Author
- BANCROFT, Caren C1 ; CHEN, Zhong1 ; YEH, Jason1 ; SUNWOO, John B1 ; YEH, Ning T1 ; JACKSON, Sadhana1 ; JACKSON, Chad1 ; VAN WAES, Carter1
[1] Tumor Biology Section, Head and Neck Surgery Branch, The National Institute on Deafness and Other Communication Disorders, The National Institutes of Health, Bethesda, MD, United States - Source
International journal of cancer. = Journal international du cancer. 2002, Vol 99, Num 4, pp 538-548 ; ref : 58 ref
- CODEN
- IJCNAW
- ISSN
- 0020-7136
- Scientific domain
- Medical oncology
- Publisher
- Wiley-Liss, New York, NY
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- 1-Phosphatidylinositol 3-kinase Activation Carcinogenèse Carcinome épidermoïde Facteur angiogène Facteur croissance endothélium vasculaire Facteur croissance épiderme Facteur transcription NFκB Homme Interleukine 8 Lignée cellulaire établie Mitogen-activated protein kinase Multiplication cellulaire Promotion carcinogenèse Tête cou Extracellular signal-regulated kinase Facteur transcription AP1 Lignée 11B Lignée UM SCC 9 Cytokine Enzyme Facteur croissance ORL pathologie Polypeptide Transferases Tumeur maligne
- Keyword (en)
- 1-Phosphatidylinositol 3-kinase Activation Carcinogenesis Squamous cell carcinoma Angiogenic factor Vascular endothelium growth factor Epidermal growth factor Transcription factor NFκB Human Interleukin 8 Established cell line Mitogen-activated protein kinase Cell proliferation Tumor promotion Head and neck Transcription factor AP1 Cytokine Enzyme Growth factor ENT disease Polypeptide Transferases Malignant tumor
- Keyword (es)
- 1-Phosphatidylinositol 3-kinase Activación Carcinogénesis Carcinoma epidermoide Factor angiógeno Factor crecimiento endotelio vascular Factor crecimiento epidermi Factor transcripción NFκB Hombre Interleuquina 8 Línea celular establecida Mitogen-activated protein kinase Multiplicación celular Promoción carcinogénesis Cabeza cuello Citoquina Enzima Factor crecimiento ORL patología Polipéptido Transferases Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B10 Otorhinolaryngology. Stomatology / 002B10A Otorhinolaryngology (head neck, general aspects and miscellaneous) / 002B10A01 Tumors
- Discipline
- Otorhinolaryngology. Stomatology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 13668492
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1002/ijc.10398 
https://dx.doi.org/10.1002/ijc.10398
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/ijc.10398\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:212:\"Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-KB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines\";s:9:\"\u0000*\u0000jtitle\";s:31:\"International journal of cancer\";s:9:\"\u0000*\u0000stitle\";s:14:\"Int. j. cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"99\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"538\";s:8:\"\u0000*\u0000epage\";s:3:\"548\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0020-7136\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"BANCROFT\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Caren C\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:11:\"CHEN, Zhong\";i:1;s:10:\"YEH, Jason\";i:2;s:14:\"SUNWOO, John B\";i:3;s:11:\"YEH, Ning T\";i:4;s:16:\"JACKSON, Sadhana\";i:5;s:13:\"JACKSON, Chad\";i:6;s:16:\"VAN WAES, Carter\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"IJCNAW\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:212:\"Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-KB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:10:\"Wiley-Liss\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/ijc.10398\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:212:\"Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-KB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines\";s:9:\"\u0000*\u0000jtitle\";s:31:\"International journal of cancer\";s:9:\"\u0000*\u0000stitle\";s:14:\"Int. j. cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"99\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"538\";s:8:\"\u0000*\u0000epage\";s:3:\"548\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0020-7136\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"BANCROFT\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Caren C\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:11:\"CHEN, Zhong\";i:1;s:10:\"YEH, Jason\";i:2;s:14:\"SUNWOO, John B\";i:3;s:11:\"YEH, Ning T\";i:4;s:16:\"JACKSON, Sadhana\";i:5;s:13:\"JACKSON, Chad\";i:6;s:16:\"VAN WAES, Carter\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"IJCNAW\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:212:\"Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-KB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:10:\"Wiley-Liss\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/ijc.10398\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/ijc.10398\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:212:\"Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-KB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines\";s:9:\"\u0000*\u0000jtitle\";s:31:\"International journal of cancer\";s:9:\"\u0000*\u0000stitle\";s:14:\"Int. j. cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"99\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"538\";s:8:\"\u0000*\u0000epage\";s:3:\"548\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0020-7136\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"BANCROFT\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Caren C\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:11:\"CHEN, Zhong\";i:1;s:10:\"YEH, Jason\";i:2;s:14:\"SUNWOO, John B\";i:3;s:11:\"YEH, Ning T\";i:4;s:16:\"JACKSON, Sadhana\";i:5;s:13:\"JACKSON, Chad\";i:6;s:16:\"VAN WAES, Carter\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"IJCNAW\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:212:\"Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-KB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:10:\"Wiley-Liss\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/ijc.10398\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:212:\"Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-KB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines\";s:9:\"\u0000*\u0000jtitle\";s:31:\"International journal of cancer\";s:9:\"\u0000*\u0000stitle\";s:14:\"Int. j. cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"99\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"538\";s:8:\"\u0000*\u0000epage\";s:3:\"548\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0020-7136\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"BANCROFT\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Caren C\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:11:\"CHEN, Zhong\";i:1;s:10:\"YEH, Jason\";i:2;s:14:\"SUNWOO, John B\";i:3;s:11:\"YEH, Ning T\";i:4;s:16:\"JACKSON, Sadhana\";i:5;s:13:\"JACKSON, Chad\";i:6;s:16:\"VAN WAES, Carter\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"IJCNAW\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:212:\"Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-KB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:10:\"Wiley-Liss\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/ijc.10398\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:212:\"Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-KB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines\";s:9:\"\u0000*\u0000jtitle\";s:31:\"International journal of cancer\";s:9:\"\u0000*\u0000stitle\";s:14:\"Int. j. cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"99\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"538\";s:8:\"\u0000*\u0000epage\";s:3:\"548\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0020-7136\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"BANCROFT\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Caren C\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:11:\"CHEN, Zhong\";i:1;s:10:\"YEH, Jason\";i:2;s:14:\"SUNWOO, John B\";i:3;s:11:\"YEH, Ning T\";i:4;s:16:\"JACKSON, Sadhana\";i:5;s:13:\"JACKSON, Chad\";i:6;s:16:\"VAN WAES, Carter\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"IJCNAW\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:212:\"Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-KB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:10:\"Wiley-Liss\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
